InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Yea Christopher, Chief Development Officer. Officer active across 1 company, notably KalVista Pharmaceuticals, Inc.. Cumulatively, 27 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €827k. History available since 3 May 2021. The latest transaction was disclosed on 20 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations27 total
87,390 shares@ US$0.0043Common StockSEC:0001691102-25-000004:0
4,205 sharesCommon StockSEC:0001691102-25-000003:0
3,125 sharesCommon StockSEC:0001415889-25-023070:0
3,750 sharesCommon StockSEC:0001415889-25-022968:0
4,203 sharesCommon StockSEC:0001415889-25-022306:0
60,000 sharesCommon StockSEC:0001415889-25-019656:0
3,750 sharesCommon StockSEC:0001415889-25-014475:0
4,205 sharesCommon StockSEC:0001415889-25-013870:0
3,125 sharesCommon StockSEC:0001415889-25-005613:0
4,204 sharesCommon StockSEC:0001415889-25-004773:0
3,125 sharesCommon StockSEC:0001415889-24-027908:0
11,496 sharesCommon StockSEC:0001415889-24-027273:0
3,125 sharesCommon StockSEC:0001415889-24-022257:0
11,495 sharesCommon StockSEC:0001415889-24-021968:0
18,789 sharesCommon StockSEC:0001415889-24-014000:0
18,788 sharesCommon StockSEC:0001415889-24-004716:0
39,886 shares@ US$15.009356.4% of flowCommon StockSEC:0001415889-24-004117:0
60,000 sharesCommon StockSEC:0001415889-24-003478:0
11,497 sharesCommon StockSEC:0001209191-23-056272:0
11,494 sharesCommon StockSEC:0001209191-23-046822:0
4,205 sharesCommon StockSEC:0001209191-23-031295:0
4,204 sharesCommon StockSEC:0001209191-23-012317:0
1,774 sharesCommon StockSEC:0001209191-22-058136:0
1,773 sharesCommon StockSEC:0001209191-22-046880:0
5,000 shares@ US$18.06560.0055% mcap18.1% of flowCommon StockSEC:0001209191-21-062730:0
25 of 27 declarations
About Yea Christopher
Christopher Yea is the Chief Development Officer at KalVista Pharmaceuticals, Inc., a company focused on developing innovative treatments for rare diseases. In his role, Christopher is responsible for the business development strategy and market expansion opportunities for the company. His expertise in the pharmaceutical field contributes to KalVista's mission of improving patients' lives.
